These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3671925)

  • 21. Zoledronic acid for Paget's disease of bone.
    Maricic M
    Drugs Today (Barc); 2007 Dec; 43(12):879-85. PubMed ID: 18174973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of Paget's disease of bone].
    Ziegler R; Frank K
    Dtsch Med Wochenschr; 1988 Jan; 113(3):102-5. PubMed ID: 3123193
    [No Abstract]   [Full Text] [Related]  

  • 23. [Diphosphonates in the treatment of bone metastases].
    Jung A; Fleisch H
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum osteoprotegerin and its ligand in Paget's disease of bone: relationship to disease activity and effect of treatment with bisphosphonates.
    Alvarez L; Peris P; Guañabens N; Vidal S; Ros I; Pons F; Filella X; Monegal A; Muñoz-Gomez J; Ballesta AM
    Arthritis Rheum; 2003 Mar; 48(3):824-8. PubMed ID: 12632438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of the outcome of treatment of Paget's disease of bone with bisphosphonates from short-term changes in the rate of bone resorption.
    Papapoulos SE; Frölich M
    J Clin Endocrinol Metab; 1996 Nov; 81(11):3993-7. PubMed ID: 8923849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A review of Paget's disease of bone with a focus on the efficacy and safety of zoledronic acid 5 mg.
    Abelson A
    Curr Med Res Opin; 2008 Mar; 24(3):695-705. PubMed ID: 18226324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapy of Paget's disease of bone with diphosphonates and calcitonin].
    Ziegler R; Holz G; Minne H; Delling G
    Verh Dtsch Ges Inn Med; 1978; (84):1122-5. PubMed ID: 741902
    [No Abstract]   [Full Text] [Related]  

  • 28. Zoledronic acid: a review of its use in the treatment of Paget's disease of bone.
    Keating GM; Scott LJ
    Drugs; 2007; 67(5):793-804. PubMed ID: 17385948
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paget's disease of bone.
    Freeman DA
    Am J Med Sci; 1988 Feb; 295(2):144-58. PubMed ID: 3278610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oral tiludronate: pharmacological properties and potential usefulness in Paget's disease of bone and osteoporosis.
    Reginster JY
    Bone; 1992; 13(5):351-4. PubMed ID: 1419375
    [No Abstract]   [Full Text] [Related]  

  • 31. Moderate Paget's disease treated with pamidronate: comparison of various infusion rates for a 60-mg single dose.
    Thiebaud D; Portmann L; Burckhardt P
    Semin Arthritis Rheum; 1994 Feb; 23(4):279. PubMed ID: 8009257
    [No Abstract]   [Full Text] [Related]  

  • 32. [Paget's disease: case report].
    Wegierska M; Ignaczak P; Zalewska J; Jeka S
    Ann Acad Med Stetin; 2011; 57(3):64-9; discussion 69. PubMed ID: 23383549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. (Chloro-4 phenyl) thiomethylene biphosphonate in Paget's bone disease.
    Reginster JY; Deroisy R; Lecart MP; Franchimont P
    Acta Belg Med Phys; 1989; 12(2):47-52. PubMed ID: 2603591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paget's disease and bisphosphonates.
    Liel Y
    N Engl J Med; 2005 Dec; 353(24):2616-8; author reply 2616-8. PubMed ID: 16354901
    [No Abstract]   [Full Text] [Related]  

  • 35. [Guidelines for improved therapeutic strategy in patients with Paget's osteitis deformans].
    Ringe JD; Reginster JY; Gennari C; Hosking DJ; Meunier PJ
    Z Rheumatol; 1996; 55(4):256-9. PubMed ID: 8967186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paget's disease of bone: presentation, extent and response to bisphosphonates.
    Wang LM; Au-Yeong ML; McKenna MJ
    Ir Med J; 2002 Sep; 95(8):244, 246. PubMed ID: 12405502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Paget's disease of bone treated with APD in 5 days].
    Staehelin-Bosshard A
    Schweiz Med Wochenschr; 1987 May; 117(19):736-7. PubMed ID: 3589630
    [No Abstract]   [Full Text] [Related]  

  • 38. What is "resistance" in Paget's disease of bone?
    Lyles KW
    Arthritis Rheum; 2003 Aug; 48(8):2097-9. PubMed ID: 12905461
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of Paget's disease of bone with intravenous pamidronate: comparison of 2 different modes of treatment.
    Ismail AA; Fox P; Stamp TC; Dhillon V; Crisp AJ; MacGregor A
    J Rheumatol; 1997 Nov; 24(11):2266-7. PubMed ID: 9375899
    [No Abstract]   [Full Text] [Related]  

  • 40. Acquired resistance to bisphosphonates in Paget's disease of bone.
    Papapoulos SE; Eekhoff EM; Zwinderman AH
    J Bone Miner Res; 2006 Dec; 21 Suppl 2():P88-91. PubMed ID: 17229015
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.